An Extended Access Program (EAP) for Participants Who Have Completed

Updated 04/23/2024

Status Available

Clinical Trial Summary

This is an extended access study for participants who have completed Rufinamide Study E2080-G000-303 to continue to have access to rufinamide until it becomes commercially available in Poland or until no participants remain in the EAP.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03778424
Study type	Expanded Access
Source	Eisai Inc.
Contact	Eisai Medical Information
Phone	1-888-274-2378
Email	esi_medinfo@eisai.com
Status	Available
Phase

See also
	Status	Clinical Trial	Phase
	Withdrawn	`NCT02910297` - The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
	Recruiting	`NCT05339126` - RNS System LGS Feasibility Study	Phase 2
	Active, not recruiting	`NCT03355209` - A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome	Phase 3
	Completed	`NCT04062981` - Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome	Phase 1
	Not yet recruiting	`NCT05066217` - EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome	Phase 2
	Recruiting	`NCT04611438` - Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome	Phase 3
	Completed	`NCT05364021` - Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies	Phase 1/Phase 2
	Terminated	`NCT03955432` - Long-term Cardiac Monitoring in Epilepsy	N/A
	Completed	`NCT02224560` - Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults	Phase 3
	Not yet recruiting	`NCT05485831` - Epidyolex® in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY
	Recruiting	`NCT05044819` - Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution	Phase 4
	Not yet recruiting	`NCT05374824` - Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
	Active, not recruiting	`NCT02655198` - Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy	Phase 2
	Completed	`NCT03467113` - A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol	Phase 1
	Completed	`NCT03731715` - Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome	Phase 1
	Recruiting	`NCT05219617` - Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults	Phase 3
	Active, not recruiting	`NCT03936777` - A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome	Phase 3
	Available	`NCT02307578` - An Extended Access Program (EAP) for Perampanel
	Available	`NCT06149663` - Intermediate-Size Expanded Access Protocol (EAP) for LP352